Compare Stocks: AQST, HRMY, PBH, and BHC

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AQST Aquestive Therapeutics	$4.78 +0.4%	$4.69	$2.93 ▼ $7.55	$597.43M	1.49	2.19 million shs	1.69 million shs
BHC Bausch Health Cos	$6.05 +0.1%	$6.20	$4.33 ▼ $8.00	$2.26B	0.37	2.04 million shs	1.03 million shs
HRMY Harmony Biosciences	$40.28 +1.7%	$40.07	$25.52 ▼ $43.49	$2.31B	1.01	1.03 million shs	487,113 shs
PBH Prestige Consumer Healthcare	$48.20 +0.7%	$49.59	$42.62 ▼ $71.07	$2.27B	0.34	657,261 shs	323,705 shs

Don't Wait for the OpenAI IPO

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AQST Aquestive Therapeutics	+3.03%	+7.21%	-8.64%	+15.53%	-23.23%
BHC Bausch Health Cos	-1.79%	+5.59%	-6.06%	+26.60%	-4.95%
HRMY Harmony Biosciences	+0.66%	+0.08%	-5.87%	+7.49%	+49.10%
PBH Prestige Consumer Healthcare	+0.62%	+7.14%	-3.87%	-2.15%	-24.40%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AQST Aquestive Therapeutics	$4.78 +0.4%	$4.69	$2.93 ▼ $7.55	$597.43M	1.49	2.19 million shs	1.69 million shs
BHC Bausch Health Cos	$6.05 +0.1%	$6.20	$4.33 ▼ $8.00	$2.26B	0.37	2.04 million shs	1.03 million shs
HRMY Harmony Biosciences	$40.28 +1.7%	$40.07	$25.52 ▼ $43.49	$2.31B	1.01	1.03 million shs	487,113 shs
PBH Prestige Consumer Healthcare	$48.20 +0.7%	$49.59	$42.62 ▼ $71.07	$2.27B	0.34	657,261 shs	323,705 shs

Don't Wait for the OpenAI IPO

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AQST Aquestive Therapeutics	+3.03%	+7.21%	-8.64%	+15.53%	-23.23%
BHC Bausch Health Cos	-1.79%	+5.59%	-6.06%	+26.60%	-4.95%
HRMY Harmony Biosciences	+0.66%	+0.08%	-5.87%	+7.49%	+49.10%
PBH Prestige Consumer Healthcare	+0.62%	+7.14%	-3.87%	-2.15%	-24.40%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AQST Aquestive Therapeutics	2.83	Moderate Buy	$8.60	79.92% Upside
BHC Bausch Health Cos	2.14	Hold	$8.00	32.34% Upside
HRMY Harmony Biosciences	2.36	Hold	$47.44	17.79% Upside
PBH Prestige Consumer Healthcare	2.40	Hold	$67.67	40.40% Upside

Current Analyst Ratings Breakdown

Latest AQST, HRMY, PBH, and BHC Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
10/8/2026	BHC Bausch Health Cos	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sector Perform	$9.00
10/1/2026	HRMY Harmony Biosciences	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Hold	$42.00
9/30/2026	PBH Prestige Consumer Healthcare	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold ➝ Strong-Buy
9/24/2026	HRMY Harmony Biosciences	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Outperform
9/22/2026	PBH Prestige Consumer Healthcare	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D+)
9/21/2026	BHC Bausch Health Cos	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold ➝ Strong-Buy
9/10/2026	AQST Aquestive Therapeutics	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Overweight	$11.00
8/26/2026	HRMY Harmony Biosciences	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Outperform	$60.00
8/24/2026	AQST Aquestive Therapeutics	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$10.00
8/20/2026	BHC Bausch Health Cos	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Strong Sell ➝ Hold
8/17/2026	HRMY Harmony Biosciences	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold (C) ➝ Hold (C+)

(Data available from 10/9/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AQST Aquestive Therapeutics	$54.09M	11.09	N/A	N/A	($0.28) per share	-17.07
BHC Bausch Health Cos	$10.85B	0.21	$7.20 per share	0.84	$1.02 per share	5.93
HRMY Harmony Biosciences	$959.90M	2.44	$3.26 per share	12.37	$15.11 per share	2.67
PBH Prestige Consumer Healthcare	$1.09B	2.10	$5.28 per share	9.13	$39.89 per share	1.21

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AQST Aquestive Therapeutics	-$83.78M	-$0.65	N/A	N/A	N/A	-144.63%	N/A	-52.40%	11/4/2026 (Estimated)
BHC Bausch Health Cos	$157M	-$2.96	N/A	1.50	N/A	-10.12%	-561.95%	6.31%	10/28/2026 (Estimated)
HRMY Harmony Biosciences	$158.69M	$3.08	13.08	9.92	0.31	18.88%	20.06%	14.15%	11/3/2026 (Estimated)
PBH Prestige Consumer Healthcare	$190.30M	$3.57	13.50	9.47	1.49	15.57%	11.39%	5.66%	11/5/2026 (Estimated)

Latest AQST, HRMY, PBH, and BHC Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
11/5/2026	Q2 2027	PBH Prestige Consumer Healthcare	$1.07	N/A	N/A	N/A	$329.15 million	N/A
11/4/2026	Q3 2026	AQST Aquestive Therapeutics	-$0.10	N/A	N/A	N/A	$11.02 million	N/A
11/3/2026	Q3 2026	HRMY Harmony Biosciences	$1.11	N/A	N/A	N/A	$274.55 million	N/A
10/28/2026	Q3 2026	BHC Bausch Health Cos	$1.24	N/A	N/A	N/A	$2.72 billion	N/A
8/11/2026	Q2 2026	AQST Aquestive Therapeutics	-$0.1050	-$0.18	-$0.0750	-$0.18	$11.42 million	$13.82 million
8/6/2026	Q1 2027	PBH Prestige Consumer Healthcare	$0.8940	$0.98	+$0.0860	$0.61	$253.02 million	$265.71 million
8/4/2026	Q2 2026	HRMY Harmony Biosciences	$0.9560	$1.28	+$0.3240	$1.28	$250.77 million	$261.28 million
7/29/2026	Q2 2026	BHC Bausch Health Cos	$0.96	$1.26	+$0.30	$0.68	$2.59 billion	$2.83 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
AQST Aquestive Therapeutics	N/A	N/A	N/A	N/A	N/A
BHC Bausch Health Cos	N/A	N/A	N/A	N/A	N/A
HRMY Harmony Biosciences	N/A	N/A	N/A	N/A	N/A
PBH Prestige Consumer Healthcare	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AQST Aquestive Therapeutics	N/A	7.19	6.74
BHC Bausch Health Cos	N/A	1.44	1.08
HRMY Harmony Biosciences	0.13	3.48	3.45
PBH Prestige Consumer Healthcare	1.06	3.23	1.99

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AQST Aquestive Therapeutics	32.45%
BHC Bausch Health Cos	78.65%
HRMY Harmony Biosciences	86.23%
PBH Prestige Consumer Healthcare	99.95%

Insider Ownership

Company	Insider Ownership
AQST Aquestive Therapeutics	6.81%
BHC Bausch Health Cos	20.67%
HRMY Harmony Biosciences	11.00%
PBH Prestige Consumer Healthcare	1.50%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AQST Aquestive Therapeutics	147	125.51 million	116.97 million	Optionable
BHC Bausch Health Cos	20,300	374.38 million	297.00 million	Optionable
HRMY Harmony Biosciences	293	58.24 million	51.83 million	Optionable
PBH Prestige Consumer Healthcare	890	47.38 million	46.66 million	Optionable

AQST, HRMY, PBH, and BHC Headlines

Recent News About These Companies

163,834 Shares in Prestige Consumer Healthcare Inc. $PBH Bought by Congress Asset Management Co.

October 8 at 3:04 AM | marketbeat.com

Prestige Consumer Healthcare (NYSE:PBH) Stock Rating Upgraded by Zacks Research

October 2, 2026 | marketbeat.com

Best Value Stocks to Buy for October 1st

October 1, 2026 | zacks.com

PBH vs. NEOG: Which Stock Is the Better Value Option?

September 30, 2026 | zacks.com

More Than Half of U.S. Women Have Avoided Talking About an Intimate Wellness Concern Because They Felt Embarrassed or Uncomfortable, New Summer's Eve® Survey Finds

September 30, 2026 | prnewswire.com

Has Prestige Consumer Healthcare (PBH) Fallen Far Enough On Earnings?

September 29, 2026 | finance.yahoo.com

Prestige Consumer Healthcare (PBH) Could Be 30% Undervalued After Its 2027 Targets

September 29, 2026 | finance.yahoo.com

Critical Contrast: GSK (NYSE:GSK) versus Prestige Consumer Healthcare (NYSE:PBH)

September 28, 2026 | americanbankingnews.com

Prestige Consumer Healthcare Eyes Clear Eyes Recovery, $270M+ Free Cash Flow

September 27, 2026 | marketbeat.com

555,894 Shares in Prestige Consumer Healthcare Inc. $PBH Purchased by Bank of America Corp DE

September 24, 2026 | marketbeat.com

Prestige Consumer Healthcare stock gains ahead of Sidoti event

September 22, 2026 | ad-hoc-news.deA

Prestige Consumer Healthcare stock falls as analysts stay cautious

September 20, 2026 | ad-hoc-news.deA

Prestige Consumer Healthcare Inc. (NYSE:PBH) Receives Consensus Recommendation of "Hold" from Brokerages

September 20, 2026 | marketbeat.com

Prestige Consumer Healthcare stock falls after sharp drop toward 52-week low

September 19, 2026 | ad-hoc-news.deA

PBH or NEOG: Which Is the Better Value Stock Right Now?

September 14, 2026 | zacks.com

Prestige Consumer Healthcare Inc. (PBH) Presents at Barclays 19th Annual Global Consumer Staples Conference Transcript

September 10, 2026 | seekingalpha.com

Prestige Consumer Healthcare Inc. to Participate in Barclays Global Consumer Conference

September 8, 2026 | globenewswire.com

Football Stress May Be Following Fans to Bed, According to the Inaugural DenTek® Football Stress Test

September 1, 2026 | prnewswire.com

PBH vs. SYK: Which Stock Is the Better Value Option?

August 28, 2026 | zacks.com

Analysts Offer Insights on NA Companies: Springer Nature AG & Co. KGaA (OtherSPGDF) and Prestige Consumer Healthcare (PBH)

August 22, 2026 | theglobeandmail.com

Nearly 40,000 eye drops recalled nationwide over possible contamination

August 21, 2026 | foxbusiness.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

AQST, HRMY, PBH, and BHC Company Descriptions

Aquestive Therapeutics NASDAQ:AQST

$4.78 +0.02 (+0.42%)

Closing price 04:00 PM Eastern

Extended Trading

$4.78 +0.00 (+0.10%)

As of 07:46 PM Eastern

Aquestive Therapeutics, Inc. operates as a pharmaceutical company in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; Zuplenz, an oral soluble film formulation of ondansetron for the treatment of nausea and vomiting associated with chemotherapy and post-operative recovery; and Azstarys, a once-daily product for the treatment of attention deficit hyperactivity disorder. Its proprietary product candidates comprise Libervant, a buccal soluble film formulation of diazepam for the treatment of seizures; KYNMOBI, a sublingual film formulation of apomorphine for the treatment of episodic off-periods in Parkinson's disease; and Exservan, an oral soluble film formulation of riluzole for the treatment of amyotrophic lateral sclerosis. The company's proprietary pipeline of complex molecule product includes AQST-108, a sublingual film formulation delivering systemic epinephrine for the treatment of conditions other than anaphylaxis; and Anaphylm, an epinephrine sublingual film for the emergency treatment of allergic reactions, including anaphylaxis. In addition, it develops Adrenaverse, an epinephrine prodrug platform. The company was incorporated in 2004 and is headquartered in Warren, New Jersey.

Bausch Health Cos NYSE:BHC

$6.04 +0.01 (+0.08%)

Closing price 03:59 PM Eastern

Extended Trading

$6.07 +0.03 (+0.48%)

As of 07:54 PM Eastern

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products in the United States. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products internationally. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; generic products; ortho dermatologic; and dentistry products in the United States. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

Harmony Biosciences NASDAQ:HRMY

$40.28 +0.68 (+1.72%)

Closing price 04:00 PM Eastern

Extended Trading

$40.16 -0.12 (-0.31%)

As of 07:30 PM Eastern

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also offers HBS-102, a melanin-concentrating hormone receptor 1 for MCH neurons. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.

Prestige Consumer Healthcare NYSE:PBH

$48.20 +0.33 (+0.68%)

Closing price 03:59 PM Eastern

Extended Trading

$48.23 +0.03 (+0.07%)

As of 07:30 PM Eastern

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, TheraTears dry eye relief, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest AQST, HRMY, PBH, and BHC Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest AQST, HRMY, PBH, and BHC Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

AQST, HRMY, PBH, and BHC Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

AQST, HRMY, PBH, and BHC Company Descriptions

Aquestive Therapeutics NASDAQ:AQST

Bausch Health Cos NYSE:BHC

Harmony Biosciences NASDAQ:HRMY

Prestige Consumer Healthcare NYSE:PBH

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest AQST, HRMY, PBH, and BHC Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest AQST, HRMY, PBH, and BHC Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

AQST, HRMY, PBH, and BHC Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

AQST, HRMY, PBH, and BHC Company Descriptions

Aquestive Therapeutics NASDAQ:AQST

Bausch Health Cos NYSE:BHC

Harmony Biosciences NASDAQ:HRMY

Prestige Consumer Healthcare NYSE:PBH

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools